Trial intelligence / Profile preview

Donepezil crossover study for cognitive dysfunction in multiple sclerosis

2005-003410-15Phase 4Completed

Sponsor
Neurology Unit
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, double-blind trial of donepezil in multiple sclerosis (MS) (2 arms), sponsored by Neurology Unit. Primary endpoint: Auditory and verbal learning. Started Sep 2005; status: completed.

02

Drugs

donepezil
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on 2005-003410-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003410-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call